Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osengleiset capsules for major depressive disorder (Phase II)
CTR20150225Phase 2Active
- Sponsor
- Kunming Institute of Botany
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of osengleiset in major depressive disorder (MDD), sponsored by Kunming Institute of Botany. Started Feb 2016; status: active.
02
Drugs
osengleiset
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20150225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150225.